Variable | aHR | 95% CI | PAF | |
---|---|---|---|---|
Age of onset (depression) ** | 1.007 | 1.005 | 1.008 | Â |
Female** | 1.24 | 1.19 | 1.29 | Â |
Lifetime physical comorbidities | ||||
 Diabetes mellitus* | 1.09 | 1.04 | 1.14 | 1.65% |
 Cardiovascular disease | 0.96 | 0.91 | 1.01 |  |
 Renal disease | 0.96 | 0.90 | 1.02 |  |
 Functional gastrointestinal disorders** | 1.19 | 1.15 | 1.24 | 5.65% |
 Thyroid dysfunction** | 1.14 | 1.07 | 1.22 | 0.87% |
Lifetime psychiatric comorbidities | ||||
 Personality disorders** | 1.23 | 1.17 | 1.29 | 4.05% |
 Substance use disorders** | 1.38 | 1.33 | 1.44 | 7.85% |
 Anxiety disorders** | 2.02 | 1.89 | 2.16 | 42.87% |
 Non-organic psychosis** | 1.19 | 1.14 | 1.24 | 6.75% |
 Severe depression** | 1.23 | 1.17 | 1.29 | 10.59% |
Converting diagnosis to bipolar disorder** | 1.68 | 1.61 | 1.75 | Â |
Prescription pattern within 1 year of onset | ||||
 Dosage of antidepressants (defined daily dose)* * | 1.002 | 1.002 | 1.002 |  |
 Dosage of benzodiazepine and its related drugs (every 10 defined daily dose)* * | 1.002 | 1.002 | 1.002 |  |
Numbers of non-psychiatric outpatient visits within 1 year prior or after onset of depression* | 1.001 | 1.000 | 1.001 | Â |